Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome
N Engl J Med
.
2026 Mar 5;394(10):1030-1033.
doi: 10.1056/NEJMc2516228.
Authors
Adrian Gottschlich
1
,
Veit Bücklein
1
,
Karim El-Marouk
1
,
Rainer Kaiser
1
,
Michael Schmid
1
,
Thomas A Janert
1
,
Michael Winkelmann
1
,
Frank Ziemann
1
,
Gerulf Hänel
1
,
Stefan Handtke
2
,
Thomas Thiele
2
,
Christian Wichmann
1
,
Sebastian Kobold
1
,
Gerhard Zugmaier
3
,
Christian Rausch
1
,
Hendrik Schulze-Koops
1
,
Lars H Lindner
1
,
Karsten Spiekermann
1
,
Michael von Bergwelt-Baildon
1
,
Marion Subklewe
1
Affiliations
1
Ludwig Maximilian University Hospital, Munich, Germany.
2
University Medicine Greifswald, Greifswald, Germany.
3
Amgen Research, Munich, Germany.
PMID:
41780009
DOI:
10.1056/NEJMc2516228
No abstract available
Publication types
Letter
Grants and funding
80735240/Deutsche Krebshilfe
GO 3823/1-1, 2021-452881907, TH 2320/3-1/Deutsche Forschungsgemeinschaft